| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.851 | Mouse |
| sarcomere organization | GO:0045214 | 24 | 0.657 | Mouse |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.548 | Mouse |
| organelle assembly | GO:0070925 | 177 | 0.502 | Mouse |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.500 | Mouse |
| muscle contraction | GO:0006936 | 101 | 0.434 | Mouse |
| actomyosin structure organization | GO:0031032 | 56 | 0.433 | Mouse |
| muscle system process | GO:0003012 | 141 | 0.424 | Mouse |
| myofibril assembly | GO:0030239 | 34 | 0.405 | Mouse |
| heart contraction | GO:0060047 | 93 | 0.383 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.345 | Mouse |
| muscle tissue development | GO:0060537 | 308 | 0.335 | Mouse |
| actin filament based movement | GO:0030048 | 23 | 0.298 | Mouse |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.295 | Mouse |
| digestive tract development | GO:0048565 | 190 | 0.289 | |
| muscle cell development | GO:0055001 | 133 | 0.284 | Mouse |
| heart morphogenesis | GO:0003007 | 178 | 0.284 | Mouse |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.282 | Mouse |
| cardiac muscle cell development | GO:0055013 | 39 | 0.276 | Mouse |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.275 | Mouse |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.273 | Mouse |
| striated muscle cell development | GO:0055002 | 125 | 0.257 | Mouse |
| myotube differentiation | GO:0014902 | 105 | 0.255 | Mouse |
| heterocycle catabolic process | GO:0046700 | 280 | 0.253 | |
| wound healing | GO:0042060 | 157 | 0.246 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.243 | Mouse |
| cardiocyte differentiation | GO:0035051 | 87 | 0.226 | Mouse |
| actin filament organization | GO:0007015 | 113 | 0.220 | Mouse |
| actin mediated cell contraction | GO:0070252 | 15 | 0.210 | Mouse |
| extracellular structure organization | GO:0043062 | 148 | 0.202 | |
| blood circulation | GO:0008015 | 195 | 0.200 | Mouse |
| circulatory system process | GO:0003013 | 197 | 0.195 | Mouse |
| cell adhesion | GO:0007155 | 329 | 0.190 | |
| regulation of cell motility | GO:2000145 | 236 | 0.190 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.188 | Mouse |
| cardiac cell development | GO:0055006 | 41 | 0.181 | Mouse |
| myosin filament assembly | GO:0031034 | 2 | 0.156 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.155 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.154 | Mouse |
| cardiac muscle contraction | GO:0060048 | 32 | 0.144 | |
| striated muscle contraction | GO:0006941 | 45 | 0.144 | |
| heart process | GO:0003015 | 94 | 0.132 | |
| cell fate commitment | GO:0045165 | 210 | 0.126 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.126 | |
| regulation of cell migration | GO:0030334 | 219 | 0.122 | |
| muscle fiber development | GO:0048747 | 76 | 0.119 | Mouse |
| epithelial cell development | GO:0002064 | 159 | 0.115 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.115 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.114 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.113 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.111 | Mouse |
| muscle cell differentiation | GO:0042692 | 261 | 0.109 | Mouse |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.109 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.109 | |
| digestive system development | GO:0055123 | 200 | 0.104 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.102 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.102 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.099 | Mouse |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.098 | |
| chronological cell aging | GO:0001300 | 1 | 0.095 | |
| lung development | GO:0030324 | 164 | 0.094 | |
| renal system development | GO:0072001 | 225 | 0.086 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.085 | Mouse |
| tissue homeostasis | GO:0001894 | 115 | 0.084 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.083 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.080 | |
| apical constriction | GO:0003383 | 4 | 0.079 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.074 | |
| myosin filament organization | GO:0031033 | 3 | 0.074 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.074 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.074 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.071 | |
| regulation of system process | GO:0044057 | 200 | 0.071 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.068 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.068 | Mouse |
| regulation of organelle organization | GO:0033043 | 289 | 0.067 | |
| negative regulation of actin filament depolymerization | GO:0030835 | 9 | 0.066 | |
| blood coagulation | GO:0007596 | 76 | 0.064 | |
| vasoconstriction | GO:0042310 | 27 | 0.063 | Mouse |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.063 | |
| protein catabolic process | GO:0030163 | 221 | 0.061 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.060 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.059 | |
| regionalization | GO:0003002 | 337 | 0.059 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.058 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.054 | |
| bone development | GO:0060348 | 120 | 0.054 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.053 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.053 | |
| oocyte construction | GO:0007308 | 2 | 0.052 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.051 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.051 | Mouse |
| male gamete generation | GO:0048232 | 285 | 0.051 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.050 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.050 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.048 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.048 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.048 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.048 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.047 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.047 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.046 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.046 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.046 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.045 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.045 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.045 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.045 | |
| endocytosis | GO:0006897 | 168 | 0.045 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.044 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.044 | |
| vascular smooth muscle contraction | GO:0014829 | 5 | 0.044 | Mouse |
| germ cell development | GO:0007281 | 185 | 0.044 | |
| intermediate filament based process | GO:0045103 | 27 | 0.044 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.044 | |
| ossification | GO:0001503 | 216 | 0.044 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.044 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.042 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.042 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.042 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.042 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.042 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.041 | |
| chondrocyte development | GO:0002063 | 24 | 0.041 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.040 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.040 | |
| transmembrane transport | GO:0055085 | 412 | 0.040 | |
| cell junction organization | GO:0034330 | 77 | 0.040 | |
| mesenchyme development | GO:0060485 | 152 | 0.039 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.039 | |
| regulation of heart rate | GO:0002027 | 36 | 0.039 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.038 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.038 | |
| hemostasis | GO:0007599 | 78 | 0.038 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.038 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.038 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.038 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.037 | |
| biomineral tissue development | GO:0031214 | 64 | 0.037 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.037 | |
| atp catabolic process | GO:0006200 | 55 | 0.037 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.037 | |
| connective tissue development | GO:0061448 | 179 | 0.036 | |
| respiratory system development | GO:0060541 | 190 | 0.036 | |
| respiratory tube development | GO:0030323 | 167 | 0.036 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.036 | |
| maintenance of location | GO:0051235 | 89 | 0.036 | |
| activation of mapk activity | GO:0000187 | 59 | 0.036 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.036 | |
| response to growth factor | GO:0070848 | 198 | 0.036 | |
| regulation of defense response | GO:0031347 | 233 | 0.035 | |
| molting cycle | GO:0042303 | 90 | 0.035 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.035 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.035 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.035 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.034 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.034 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.034 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.034 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.033 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.033 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.033 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.033 | |
| regulation of cell activation | GO:0050865 | 289 | 0.033 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.033 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.033 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.032 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.032 | |
| muscle adaptation | GO:0043500 | 39 | 0.032 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.032 | |
| regulation of tube size | GO:0035150 | 57 | 0.032 | Mouse |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.031 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.031 | |
| cardiac chamber development | GO:0003205 | 108 | 0.031 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.031 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.031 | |
| pharynx development | GO:0060465 | 1 | 0.031 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.031 | |
| regulation of actin filament depolymerization | GO:0030834 | 13 | 0.031 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.030 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.030 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.030 | |
| cellular homeostasis | GO:0019725 | 240 | 0.030 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.030 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.029 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.029 | |
| regulation of cell shape | GO:0008360 | 39 | 0.029 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.029 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.029 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.029 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.028 | |
| activation of immune response | GO:0002253 | 138 | 0.028 | |
| spermatogenesis | GO:0007283 | 284 | 0.028 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.028 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.028 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.028 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.028 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.027 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.027 | |
| cell recognition | GO:0008037 | 83 | 0.027 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.027 | |
| ovulation | GO:0030728 | 15 | 0.027 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.027 | |
| protein localization to membrane | GO:0072657 | 108 | 0.027 | |
| oocyte axis specification | GO:0007309 | 2 | 0.027 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.027 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.027 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.026 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.026 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.026 | |
| microtubule based process | GO:0007017 | 236 | 0.026 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.026 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.026 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.026 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.026 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.025 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.025 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.025 | |
| response to inorganic substance | GO:0010035 | 96 | 0.025 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.025 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.025 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.024 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.024 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.024 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.024 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.024 | |
| cell aging | GO:0007569 | 35 | 0.024 | |
| bone morphogenesis | GO:0060349 | 78 | 0.024 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.024 | |
| negative regulation of endocytosis | GO:0045806 | 12 | 0.024 | |
| glomerulus development | GO:0032835 | 40 | 0.024 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.024 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.024 | |
| stem cell development | GO:0048864 | 219 | 0.023 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.023 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.023 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.023 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.023 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.023 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.023 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.023 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.023 | |
| dendrite development | GO:0016358 | 115 | 0.022 | |
| microglia development | GO:0014005 | 2 | 0.022 | |
| skin development | GO:0043588 | 220 | 0.022 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.022 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.022 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.022 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.022 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.022 | |
| regulation of cell growth | GO:0001558 | 91 | 0.022 | |
| t cell activation | GO:0042110 | 289 | 0.022 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.021 | |
| oocyte differentiation | GO:0009994 | 35 | 0.021 | |
| neuron death | GO:0070997 | 154 | 0.021 | |
| fibril organization | GO:0097435 | 2 | 0.021 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.021 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.021 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.021 | |
| negative regulation of protein complex disassembly | GO:0043242 | 22 | 0.021 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 31 | 0.021 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.021 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.021 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.021 | |
| protein oligomerization | GO:0051259 | 67 | 0.020 | |
| chemotaxis | GO:0006935 | 247 | 0.020 | |
| response to amino acid | GO:0043200 | 37 | 0.020 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.020 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.020 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.020 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.020 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.020 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.020 | |
| innate immune response | GO:0045087 | 157 | 0.020 | |
| sensory perception of sound | GO:0007605 | 97 | 0.020 | |
| skeletal system development | GO:0001501 | 356 | 0.020 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.020 | |
| organelle fission | GO:0048285 | 170 | 0.019 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.019 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.019 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.019 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.019 | |
| cell division | GO:0051301 | 120 | 0.019 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.019 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.019 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.019 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.019 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.019 | |
| regulation of cell adhesion mediated by integrin | GO:0033628 | 13 | 0.019 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.019 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.019 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.019 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.018 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.018 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.018 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.018 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.018 | Mouse |
| response to metal ion | GO:0010038 | 47 | 0.018 | |
| alanine transport | GO:0032328 | 4 | 0.018 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | |
| bone trabecula morphogenesis | GO:0061430 | 12 | 0.018 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.018 | |
| epidermis development | GO:0008544 | 187 | 0.018 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.018 | |
| tissue remodeling | GO:0048771 | 102 | 0.018 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.018 | |
| immune effector process | GO:0002252 | 321 | 0.018 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.018 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.018 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.018 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.018 | |
| negative regulation of hepatocyte proliferation | GO:2000346 | 3 | 0.017 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.017 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.017 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.017 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.017 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.017 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.017 | |
| platelet activation | GO:0030168 | 40 | 0.017 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.017 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.017 | |
| microglia differentiation | GO:0014004 | 2 | 0.017 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.017 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.017 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.017 | |
| mesangial cell development | GO:0072143 | 4 | 0.017 | |
| gastrulation | GO:0007369 | 116 | 0.016 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.016 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.016 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| cell fate specification | GO:0001708 | 72 | 0.016 | |
| response to oxygen levels | GO:0070482 | 62 | 0.016 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.016 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.016 | |
| intracellular protein transport | GO:0006886 | 204 | 0.016 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.016 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.016 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.016 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.015 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.015 | |
| extracellular matrix dependent thymocyte migration | GO:0072680 | 1 | 0.015 | |
| tubulin complex biogenesis | GO:0072668 | 2 | 0.015 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.015 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.015 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.015 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.015 | |
| feeding behavior | GO:0007631 | 62 | 0.015 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.015 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.015 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.015 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.015 | |
| endomembrane system organization | GO:0010256 | 147 | 0.015 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.015 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.015 | |
| protein maturation | GO:0051604 | 176 | 0.015 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.015 | |
| cell cell junction organization | GO:0045216 | 72 | 0.015 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.015 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.015 | |
| amide transport | GO:0042886 | 138 | 0.015 | |
| female gamete generation | GO:0007292 | 74 | 0.014 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.014 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.014 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.014 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.014 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.014 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.014 | |
| thymocyte migration | GO:0072679 | 2 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.014 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.014 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.014 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.014 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.014 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.014 | |
| regulation of lamellipodium assembly | GO:0010591 | 3 | 0.014 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.014 | |
| positive regulation of transforming growth factor beta receptor signaling pathway | GO:0030511 | 12 | 0.014 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.014 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.014 | |
| actin filament polymerization | GO:0030041 | 44 | 0.014 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.014 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.014 | |
| endochondral bone growth | GO:0003416 | 19 | 0.014 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.014 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.013 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.013 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.013 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.013 | |
| gland development | GO:0048732 | 330 | 0.013 | |
| phagocytosis | GO:0006909 | 66 | 0.013 | |
| cation transport | GO:0006812 | 399 | 0.013 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.013 | |
| cytokinetic process | GO:0032506 | 2 | 0.013 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.013 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.013 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.013 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.013 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.013 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.013 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.013 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.013 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.013 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.013 | |
| early endosome to late endosome transport | GO:0045022 | 2 | 0.013 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.013 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.013 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.013 | |
| protein polymerization | GO:0051258 | 57 | 0.013 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.013 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.013 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.013 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.013 | |
| cartilage development | GO:0051216 | 140 | 0.013 | |
| dna metabolic process | GO:0006259 | 303 | 0.013 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.013 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.013 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.013 | |
| protein depolymerization | GO:0051261 | 34 | 0.013 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.013 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.013 | |
| placenta development | GO:0001890 | 140 | 0.013 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.013 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.013 | |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.013 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.013 | |
| response to hypoxia | GO:0001666 | 58 | 0.013 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.013 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.013 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.013 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.012 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.012 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.012 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.012 | |
| regulation of ossification | GO:0030278 | 112 | 0.012 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.012 | |
| activation of mapk activity involved in innate immune response | GO:0035419 | 2 | 0.012 | |
| negative regulation of t helper 2 cell differentiation | GO:0045629 | 4 | 0.012 | |
| developmental maturation | GO:0021700 | 193 | 0.012 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.012 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.012 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.012 | |
| head morphogenesis | GO:0060323 | 34 | 0.012 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.012 | |
| lipid localization | GO:0010876 | 126 | 0.012 | |
| positive regulation of bone resorption | GO:0045780 | 13 | 0.012 | |
| protein ubiquitination | GO:0016567 | 171 | 0.012 | |
| protein localization to organelle | GO:0033365 | 185 | 0.012 | |
| protein complex disassembly | GO:0043241 | 40 | 0.012 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.012 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.012 | |
| prevention of polyspermy | GO:0060468 | 4 | 0.012 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.012 | |
| liver development | GO:0001889 | 66 | 0.012 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.012 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.012 | |
| actin filament depolymerization | GO:0030042 | 15 | 0.012 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.012 | |
| mesoderm development | GO:0007498 | 100 | 0.012 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.012 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.012 | |
| ovulation cycle | GO:0042698 | 59 | 0.012 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.012 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.012 | |
| pole plasm assembly | GO:0007315 | 2 | 0.012 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.011 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.011 | |
| female gonad development | GO:0008585 | 71 | 0.011 | |
